One of the Greene-Jensen antibodies generated against oestrogen receptor from MCF-7 breast cancer cells is now marketed in the form of a kit (ER-ICA) by Abbott Laboratories Ltd, and in our hands, the results, in agreement with other reports, are very promising.
Thirty-four breast cancers were received on ice from operating theatres in the Edinburgh and Fife regions within -1 h of excision. A portion of tumour was cut from the face of the tissue and fixed in formol-saline for routine histopathology, a second portion (-350 mg) was used immediately for biochemical assay of oestrogen receptor activity by a standard DCC assay used in these laboratories since November 1973 with one minor modification (Hawkins et al., 1981) Figure 1 , where the histochemical assay result (staining intensity) is plotted against the biochemical assay result (fmol receptor sitesmg-1 protein). Of the tissues, 27 (i.e. 79%) were biochemically receptor-positive and 7 (21%) were receptor negative (i.e. <5 fmol sites mg-1 protein). Histochemically, 25 (i.e. 74%) showed some staining whilst the remaining 9 tissues, all with biochemically determined receptor concentrations of < 10 fmol mg-1 protein, showed no detectable trace of staining. There was a strong correlation between either the intensity of staining (Figure 1 (Hawkins et al., 1977 , Masters et al., 1978 , Hawkins et al., 1981 and as might be expected from the localisation of receptors in the epithelial cells of the tumour. In the present study, although the tumour cellularity differed between the portion selected for histochemical assay and that selected for biochemical assay, the differences were slight in 33 out of 34 tumours and severe in only one case (7% vs. 37%). In order to facilitate comparison of histochemical and biochemical results, a 'staining index' (representing the total staining in the specimen) was calculated as follows:
Staining index = Staining intensity x % cel g 100 % cellularity 100 (This was calculated using the cellularity of the 'biochemical specimen to minimise discrepancies due to the use of non-identical portions of tissue in the two assays). Staining index, too, was strongly correlated with biochemically determined receptor site concentration (correlation coefficient= +0.87, P<0.001) as shown in Figure 3 .
These results strongly suggest that the histochemical assay described detects accurately the classical oestrogen receptor as determined by biochemical binding assays. Although others Thorpe et al., 1985; Pertschuk et al., 1985; McLelland & Coombes, 1985; Harper et al., 1985) have previously reported such a correlation, we felt it important to report our confirmatory findings after our previous disappointing experiences with other assays of this type. Biochemically-detected receptor sites (fmol mg-' protein) Figure 3 The correlation between histochemical staining for oestrogen receptors, corrected for the proportion of specimen not staining, and receptor concentration determined biochemically in 34 breast cancers. 'Staining index' = staining intensity x fraction of tissue occupied by cells x fraction of cells staining.
In order to render histochemical and biochemical assays comparable, staining index has been calculated using the fraction of tissue occupied by cells in the specimen used for biochemistry. F = + 0.87.
to quantify histochemical assays precisely, the assay, in our hands, starts to detect receptor activity at concentrations around 20-40fmol biochemical sitesmg-1 protein; this cut-off is fairly close to that used routinely in this department for treatment decisions (20fmolmg-1 protein) and is very 'safe' as judged by other reports in relation to treatment of advanced disease (Cant et al., 1985) or adjuvant therapy (Rose et al., 1985; Stewart & Prescott 1985) . That the assay is as good as, or better than, the biochemical procedure in identifying responders to endocrine treatment in advanced disease has already been demonstrated directly by McLelland and Coombes (1985) . We consider these preliminary results to be successful and believe that the technique shows great potential for (i) assay of small specimens, (ii) identification of tumours with a heterogeneous population of cells with respect to receptor status and (iii) application to cytological aspirates. 
